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ABSTRACT
Sepsis is a leading cause of preventable maternal mortality in developing countries due to poverty, home
deliveries by untrained persons in unhygienic conditions, limited access to healthcare facilities and lack
of availability of antibiotics. Recent confidential enquiries into maternal deaths from the developed
nations have revealed an increase in maternal mortality secondary to genital tract sepsis and provision of
suboptimal critical care. Early recognition of critical illness in obstetric patients, involvement of intensive
care teams earlier and provision of same standard of critical care to pregnant women as non-pregnant
patients while being mindful of the altered maternal physiology and fetal wellbeing is necessary to
improve outcome of this vulnerable population.
This article reviews the definitions and risk factors of maternal sepsis and describes the standards
recommended for efficient delivery of maternal critical care and sepsis management.
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INTRODUCTION
Sepsis is responsible for causing more deaths
globally than prostate cancer, breast cancer and HIV/
AIDS combined1 and is the one of the most common
causes of mortality in the intensive care units.2 In
the developing world, 60-80% of childhood deaths
are due to sepsis resulting in the death of over 6
million newborns and children every year along
with over 100,000 cases of maternal sepsis3 The 8th
report of The Confidential Enquiry into Maternal
Deaths (CEMCH) published in March 2011 showed
a decrease in the overall maternal mortality rate in
UK from13.95 to 11.39 per 100,000 deliveries but
the report indicated an increase in deaths related to
genital tract infections and sepsis was rated as the
most common cause of direct maternal death.4
Admission rate of obstetric patients to general or
surgical critical care units varies from 0.05-1.7% of
total admissions in developed countries5 to about
11.6% in developing countries.6 Recent ICNARC
(Intensive Care National Audit and Research Centre)
Case Mix Programme (CMP) data showed that 11.4%
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of women between the age of 16 years and 50 years
who were admitted to adult general intensive care
units in England, Wales and Northern Ireland were
either pregnant or recently pregnant.7 Critically ill
obstetric patients present a unique challenge to
the intensivists due to altered maternal physiology
and concerns regarding fetal safety and outcome.
Early recognition of critical illness, involvement of
intensive care teams earlier and provision of same
standard of critical care to pregnant women as nonpregnant patients is necessary to improve survival
of critically ill women in the peripartum period.8
The objective of this article is to review the definitions
and underlying causes of maternal sepsis which is a
re-emerging threat to maternal health and describe
the standards recommended for efficient delivery
of maternal critical care and sepsis management.

DEFINING MATERNAL SEPSIS
Globally 10% of maternal deaths are caused by
sepsis, and the incidence is highest in Southeast Asia
(13.2%) and Africa (10%) 9. However, describing the
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total burden of maternal sepsis is challenging for a
number of reasons. Firstly there is a lack of a uniform
definition of maternal sepsis. Secondly there is
confusion whether to include maternal deaths
resulting from genital tract sepsis only or to include
maternal deaths resulting from all other sources of
infection like urinary tract infections, respiratory
tract infections, mastitis, malaria, hepatitis, dengue
fever, HIV, and nosocomial infections.10,11 Thirdly
there is gross underreporting of sepsis and
maternal deaths in the developing countries where
the burden of disease is the greatest due to lack of
data of home deliveries and absence of postnatal
follow-up after hospital discharge.12
Another reason ismisclassification of the cause of
the maternal deaths as ‘indirect cause’ instead of
sepsis being the ‘direct cause’ of maternal death in
countries where endemic diseases like HIV, malaria
and tuberculosis are highly prevalent or in the
presence of significant comorbid diseases.13
World Health Organization (WHO) defines
Puerperal Sepsis as, “infection of the genital
tract occurring at any time between the onset of
rupture of membranes or labour and the 42nd
day postpartum in which fever and one or more of
the following are present: pelvic pain, abnormal
vaginal discharge, abnormal smell/foul odour of
discharge and delay in the rate of reduction of the
size of the uterus”.14
International Classification of Diseases (ICD-10)
defines ‘Puerperal Sepsis’ as, “temperature rise
above 38.08ºC (100.48ºF) maintained over 24 hrs
or recurring during the period from the end of the
first to the end of the 10th day after childbirth or
abortion”.

American College of Chest Physicians and the
Society of Critical Care Medicine attempted to
standardize definitions15 for systemic inflammatory
response syndrome (SIRS), sepsis, severe sepsis
and septic shock in 1992 (Table 1) which were later
elaborated at an international sepsis definition
conference in 2001.16 Onset of labour and rupture
of membranes triggers symptoms of SIRS even
without the presence of an infection and may mask
a serious infection.

RISK FACTORS OF SEPSIS DURING
PREGNANCY
Pregnant women are highly susceptible to
infection because the maternal immune response
is down-regulated to protect the immunologically
distinct foetus17 and there is loss of the protective
physiological barriers against bacterial infection
with the onset of labour.11
The surgical site and the endometrium is exposed
to pathogens during Cesarean section, increasing
the risk of severe infections five to 20-fold in women
who undergo operative delivery as compared
to women who deliver naturally.18 Increased
incidence of caesarian sections and obesity are two
most important factors contributing to increased
maternal mortality due to sepsis in UK.19
Poverty, home deliveries by untrained persons in
unhygienic conditions, limited access to healthcare
facilities and lack of availability of antibiotics are
the most important factors that increase the risk
of maternal sepsis in developing countries.20 HIVrelated infections are the main cause of maternal
mortality in sub-Saharan and southern Africa.21

Table 1: Definitions related to sepsis [15]
SIRS
Two of the following
• Heart rate ≥ 90 bpm
• Respiratory rate
≥ 20 bpm or PaCO2 < 32
mmHg
• Temperature
≥ 38°C or ≤ 36°C
• WBC ≥12000 or ≤
4000 cells/µL or ≥10%
immature forms

Sepsis
SIRS with a suspected or
documented
source of infection
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Severe Sepsis
Sepsis associated with organ
dysfunction i.e.
•
Decreased GCS
•
Decreased urine output
<0.5ml/kg/hr for > 2 hrs
•
Creatinine > 2 mg/dl
•
Bilirubin > 2 mg/dl
•
INR >1.5
•
Acute Lung Injury with PaO2/
FiO2 <300
•
Plasma C-reactive Protein>2
SD above normal
•
Serum Lactate > 4 mmol/L

Septic shock
Organ dysfunction despite
adequate fluid resuscitation
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Table 2: Risk factors for severe maternal morbidity and
mortality from sepsis [13]
High income countries

Low income countries

Cesarean section

Poverty

Emergency Cesarean section

Unhygienic birth conditions

Prolonged rupture of membranes

Lack of skilled birth assistants

Retained products of conception

Long distance to healthcare facility

Early labour

Unavailable medical supplies

Multiple vaginal examinations (>5)

Young age

Obesity

Primiparity

Diabetes

Anemia

Anemia

HIV, Tuberculosis, Malaria

Low socioeconomic status

Failure to recognize severity

Winter months
Failure to recognize severity

Invasive streptococcal infections are responsible
for most cases of severe sepsis world over.22, 23
Hypervirulent strains of gram-positive Streptococcus
pyogenes or group A streptococcus (GAS) were
responsible for 45% of direct maternal deaths from
genital tract sepsis in the UK in the triennium 20062008.4 GAS resides in the human nasopharynx and
is transmitted during influenza outbreaks via the
respiratory tract or the perineum gets contaminated
directly when proper hand hygiene is not observed
resulting in genital tract infection.24

IMPACT OF CARDIORESPIRATORY
CHANGES OF PREGNANCY ON
MATERNAL CRITICAL CARE
Physiological changes of pregnancy help adapt the
mother to the requirements of the foetus and the
placenta. The hormone progesterone is a potent
smooth-muscle relaxant and respiratory stimulant
and is responsible for most of these maternal
adaptations that return to normal approximately
6 weeks after delivery.25 These cardiorespiratory
adaptations of pregnancy have a significant impact
on critical care management of the mother.
Blood volume increases progressively by up to
50%, so the mother can lose up to 30% of her
blood volume before her vital signs change. In the
event of significant maternal hypotension, placenta
experiences vasoconstriction unlike other vital
organs resulting in placental hypoperfusion, fetal
hypoxia and acidosis. Fetal distress may be the first
sign of maternal haemodynamic instability. Maternal
systolic blood pressure should be maintained at 90
438

mmHg to ensure adequate placental perfusion,
however the haemodynamic targets should be reset in view of the altered physiological variables,26
as shown in Table 3. After 20 weeks gestation the
gravid uterus can cause aortocaval compression,
decreasing uterine perfusion and venous return to
the heart. Ensuring adequate lateral maternal tilt
or manual displacement of the uterus are simple
but effective maneuvers to prevent aortocaval
compression and the resulting hypotension.
Table 3: Changes in physiological variables during late
pregnancy (Clinical Physiology in Obstetrics, 3rd edn. Oxford:
Blackwell Science;1998)

Parameter

Value change

Systolic arterial pressure

- 5 mmHg

Mean arterial pressure
Diastolic arterial pressure
Central venous pressure
Pulmonary capillary wedge
pressure
Heart rate
Stroke volume
Cardiac output
Systemic vascular resistance

-15 mmHg
-15 mmHg
No change
No change
+15%
+30%
+45%
-15%

Tidal volume
Respiratory rate
Minute volume
Oxygen consumption
pH
PaO2
PaCO2
HCO3
Total blood volume
Haematocrit
Plasma albumin
Oncotic pressure

+40%
+10%
+50%
+20%
No change
+10 mmHg
-10 mmHg
-4 mmol/l
+40%
-0.06
-5 g/l
-3 mmHg

As the uterus expands out of the pelvis during
pregnancy, the diaphragm elevates limiting the
lung expansion. Residual volume and functional
residual capacity are reduced resulting in decreased
reserve when respiratory decompensation occurs.
Tidal volume, minute ventilation and oxygen
consumption increase to cope with the increased
metabolic demands. Maintaining a maternal PaO2
> 60 mmHg will help ensure adequate foetal
oxygenation. Although changes in anatomy and
lung compliance don’t make mechanical ventilation
ANAESTH, PAIN & INTENSIVE CARE; VOL 18(4) OCT-DEC 2014
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difficult in pregnant women, the lung protective
strategies recommended for managing adult
respiratory distress syndrome (ARDS) may be more
difficult to implement.27 Low tidal volumes make
it difficult to maintain the increased ventilatory
demands of pregnancy and higher tidal volumes
and alveolar plateau pressures up to 35 cm H2O
may be necessary. Permissive hypercapnoea may
cause fetal respiratory acidosis that will reduce the
ability of foetal haemoglobin to bind oxygen. Prone
positioning recommended for severe ARDS has not
been investigated during pregnancy. Upper airway
oedema makes the airway management potentially
difficult and delayed gastric emptying increases the
risk of pulmonary aspiration

DRUG SAFETY IN PREGNANCY
Vasopressors cause vasoconstriction in all
vessels therefore while selecting a vasopressor
it is important to select an agent that preserves
uteroplacental perfusion. However vasopressors
have diverse effects on fetoplacental circulation and
the underlying pharmacodynamic mechanisms and
their clinical implications are unclear.28 Ephedrine
crosses the placenta and may cause fetal tachycardia
and acidosis. It should only be used as a bolus
agent for short-lived hypotension. Phenylephrine
may cause more uteroplacental vasoconstriction
but is associated with less fetal acidosis, better
neonatal outcomes and is more suitable when
continuous infusions are indicated.29 Dopamine is
commonly used in pregnant women with sepsis,
although both dopamine and dobutamine decrease
uterine blood flow. Vasopressin may cause uterine
contractions so it should be used cautiously in the
third trimester. Epinephrine and norepinephrine
can also cause vasoconstriction of the maternal and
placental vasculature especially in hypoxic women
and are best avoided.25
Opioids,
benzodiazepines,
propofol
and
barbiturates are relatively safe in pregnancy, even
though they easily cross the placenta. The newborn
may experience withdrawal effects if any of these
therapies have been used for more than a few
hours before delivery but infusions of these agents
in an intensive care setting are justified even if the
women delivers while still receiving them. These
agents also cross into breast milk and may cause
considerable sedation in newborns, especially
those born prematurely. Fentanyl may be a better
choice of opioid because oral absorption is low but
high-dose infusions could still cause respiratory
depression in the newborn.25
ANAESTH, PAIN & INTENSIVE CARE; VOL 18(4) OCT-DEC 2014

LEVELS OF MATERNAL CRITICAL CARE
Four levels of care are recommended for pregnant
or recently pregnant woman,30 depending on the
organ support and level of monitoring required,
and independent of the diagnosis.
Level 0 or normal ward care:
• For the care of low risk woman.
Level 1 or additional monitoring or step down from
higher level of care:
• Neuraxial analgesia
• Risk of haemorrhage
• Oxytocin infusion
• Remifentanil infusion
• Mild pre-eclampsia on oral anti-hypertensives/
fluid restriction
• Chronic medical condition at risk of deterioration
such as congenital heart disease or diabetes
requiring insulin infusion.
Level 2 or single organ support:
Basic Respiratory Support (BRS)
• 50% or more oxygen via face-mask to maintain
oxygen saturation
• Non-invasive ventilation (CPAP or BiPAP)
Basic Cardiovascular Support (BCVS)
• Infusion of anti-hypertensives (labetalol or
hydralazine) to control blood pressure in preeclampsia
• Arterial line used for pressure monitoring or
sampling
• CVP line used for fluid management and CVP
monitoring to guide therapy
Advanced Cardiovascular Support (ACVS)
• Simultaneous use of at least two intravenous, antiarrhythmic/antihypertensive/vasoactive drugs
• Need to measure and treat cardiac output
Neurological Support
• Magnesium infusion to control seizures (not
prophylaxis)
Hepatic support
Acute fulminant hepatic failure, e.g. from
HELLP syndrome or acute fatty liver, such that
transplantation is being considered
Level 3 or advanced respiratory support alone or
support of 2 or more organ systems as above
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Advanced Respiratory Support
• Invasive mechanical ventilation
Support of two or more organ systems
• Support of two or more organ systems-Renal
support and BRS; BRS/BCVS and an additional
organ supported

FETAL MONITORING IN INTENSIVE
CARE UNIT
Organ support and multiple drugs required by the
mother during critical illness may adversely affect
the fetal wellbeing. In order to ensure adequate
placental perfusion and oxygenation and avoid
premature labour it is important to monitor the
fetus in the intensive care unit along with the
maternal monitoring.
1. ULTRASOUND
Abdominal ultra sound is a non-invasive
technique that is widely available in the
intensive care units. It helps assess
• Fetal viability and position.
• Placenta location and abruption status.
• Amniotic fluid volume.
• Uterine artery blood flow.
2. CTG MONITORING
Cardiotocography (CTG) or electronic foetal
monitoring (EFM) is a technique for assessing
fetal wellbeing during labour. Following
standard terminologies are used to interpret a
CTG trace.31
• Baseline foetal heart rate (FHR) is determined
over a period of 5-10 minutes and is 110-160
beats per minute (bpm).
• Baseline variability is the minor fluctuation
in baseline FHR (6-25 bpm) assessed in one
minute segments of the trace.
• Accelerations are transient increases in FHR
of 15 bpm or more above the baseline and
lasting 15 seconds.
• Decelerations are transient episodes of
decrease of FHR below the baseline of more
than 15 bpm lasting at least 15 seconds.
Decelerations indicate an abnormal CTG. Late
decelerations are a sign of utero-placental
insufficiency and warrant prompt attention.
Close collaboration between intensivists and
the obstetricians is required for interpretation
and clinical management response to an
abnormal CTG.
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CURRENT RECOMMENDATION FOR
SEPSIS MANAGEMENT
Management of pregnant patients in sepsis is not
different from the management of other septic
patients as long as the altered maternal physiology
and wellbeing of the fetus are considered. The
normal physiological adaptations seen in pregnancy
make early detection of sepsis difficult on one
hand and may exacerbate the organ dysfunction
associated with sepsis on the other hand. Use of
modified early obstetric warning score (MEOWS)
leads to timely recognition of an obstetric patient
becoming critically ill32 and The Royal College of
Obstetrics and Gynaecology33 endorses the use of
evidence-based recommendations of the Surviving
Sepsis Campaign (SSC) to manage severe maternal
sepsis.
Following are the treatment and intervention
bundles for early goal directed therapy [34].
Initiate the following after recognition of severe
sepsis and septic shock and complete within 3
hours:
• Obtain blood culture specimens before antibiotic
administration.
• Obtain serum lactate level.
• Administer broad-spectrum antibiotic (don’t
delay more than 45 min for blood cultures).
• Initiate 30 mL/kg isotonic crystalloid fluids for
hypotension or lactate level of 4 mmol/L or
greater (may use albumin as part of initial fluid
resuscitation in patients requiring substantial
amounts of crystalloids; avoid hydroxyethyl
starches).
• Goals are to achieve a mean arterial pressure
(MAP) of 65 mm Hg and urine output >0.5 mL/
kg/hr.
Within 6 hours of recognition of severe sepsis
or septic shock:
• Infuse vasopressors (for hypotension that
doesn’t respond to initial fluid resuscitation or
for abnormally low diastolic blood pressure) to
maintain MAP of 65 mm Hg or greater. Intravenous
norepinephrine is the vasopressor of choice.
• In the event of persistent arterial hypotension
despite volume resuscitation (septic shock) or
initial lactate of 4 mmol/L or more, measure CVP
and aim for a target of 8-12 mm Hg; measure
ScvO2 and target ScvO2 or SvO2 >70% or
65%,respectively.
• Re-measure lactate if initial level was elevated.
ANAESTH, PAIN & INTENSIVE CARE; VOL 18(4) OCT-DEC 2014
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Two recent trials have challenged the effectiveness
of SSC recommendations. The preliminary results of
the Australasian Resuscitation in Sepsis Evaluation
(ARISE) trial were released at the European Society
of Intensive Care Medicine (ESICM) annual meeting
in Barcelona in September 2014 and failed to show
benefit of early goal-directed therapy. The results of
this trial came within a year after the Protocolized
Care for Early Septic Shock (ProCESS) trial released
similar findings.35
Based on the conclusions of the ProCESS and
ARISE trials, the SSC Executive Committee issued
the following statement;
• Central venous pressure (CVP) and central venous
oxygen saturation (ScvO2) monitoring as part of
an early resuscitation strategy does not confer
survival benefit in patients with septic shock who
received timely antibiotics and fluid resuscitation
compared with controls.
• CVP and ScvO2 monitoring in all patients who
have lactate levels >4 mmol/L and/or persistent
hypotension after initial fluid challenge and who
have received timely antibiotics is not supported
by robust scientific evidence.
• Results of the ProCESS and ARISE trials did not
demonstrate adverse outcome in the group
that utilized CVP and ScvO2 as end points for
resuscitation.
• In light of the evidence from the ProCESS and
ARISE trials, the SSC guidelines committee will
review the evidence and re-assess the guidelines
and if required issue a focused update.
• The current SSC bundles will not change till such
time that the new guidelines are introduced.

MATERNAL RESUSCITATION
If cardiac arrest happens in a pregnant woman after
20 weeks gestation, manual displacement of the
uterus prevents aortocaval compression, increases
venous return, cardiac output and uteroplacental
perfusion.
If initial resuscitation fails to revive the mother
following a cardiac arrest and the foetus is of
greater than 24 weeks gestation, emergency
caesarian section to deliver the foetus within 5
minutes of cardiac arrest facilitates maternal and
foetal survival.
Therapeutic hypothermia for 12-24 hours may be
considered after return of spontaneous circulation
to improve neurological outcome.33

CONCLUSIONS
Sepsis remains a leading cause of preventable
maternal death in both developed and developing
countries. Early recognition of the severity of an
infection and effective maternal resuscitation by a
multidisciplinary team of intensivists, anesthetists,
neonatologists, obstetrician, midwives and
pharmacists according to the standards set for
delivering maternal critical care is the cornerstone
for maternal and foetal wellbeing.

KEY POINTS:
• Avoid aortocaval compression after 20 weeks of
gestation by maintaining a lateral maternal tilt
• Monitor modified early obstetric warning score
(MEOWS) for early recognition of critical illness
in the obstetric population. early signs

• When revised bundles become available, they will
be posted on the SSC website and the SSC data
collection tool will be modified appropriately.

• Implement resuscitation bundle within 3 hours
of suspicion of maternal sepsis.

• The 3-hour SSC bundle will not be affected by
this process.

• Consider antenatal steroids if preterm delivery
anticipated

Till SSC issues a focused update, management of
the pregnant septic patients should continue as per
the SSC recommendation, specially the first three
hours bundle.

• Do not neglect perineal and breast care while
managing the critically ill mother in the in the
intensive care unit

Hand hygiene and intravaginal application of
antiseptics are the two main strategies described in
the current literature to prevent puerperal sepsis, in
addition to the prophylactic use of antibiotics during
elective and emergency caesarian sections.36
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• Consider thromboprophylaxis early

• Involve the pharmacist to prescribe drugs that
pose less risk to the fetus during pregnancy, are
safe if breast feeding and ensure appropriate
dosing.
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